Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pranela Rameshwar

Showing results (91-100 of 196) with videos related to

Pageof 20
Sort By:
Cancer Metastasis Reviews|May 13, 2020
Epigenetic dynamics in cancer stem cell dormancyAlejandra I Ferrer, Jonathan R Trinidad, Oleta Sandiford, et al.
Molecular and Cellular Therapies|June 10, 2015
Stem cell in alternative treatments for brain tumors: potential for gene deliveryVeronica Mariotti, Steven J Greco, Ryan D Mohan, et al.
Current Drug Discovery Technologies|June 10, 2008
Neurokinin receptors as potential targets in breast cancer treatmentBobby Y Reddy, Katarzyna A Trzaska, Raghav G Murthy, et al.
Experimental Hematology|September 13, 2002
Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptorPranela Rameshwar, Pedro Gascon, Hyun S Oh, et al.
Canadian Journal of Physiology and Pharmacology|June 12, 2002
Structural similarity between the bone marrow extracellular matrix protein and neurokinin 1 could be the limiting factor in the hematopoietic effects of substance PPranela Rameshwar, Pedro Gascon, Persis S Bandari, et al.
Shock (Augusta, Ga.)|October 19, 2004
A theoretical simulation of hematopoietic stem cells during oxygen fluctuations: prediction of bone marrow responses during hemorrhagic shockEliana S Antoniou, Steve Sund, Emile N Homsi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigensJulius A Potian, Hana Aviv, Nicholas M Ponzio, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 10, 2018
Methods of Mesenchymal Stem Cell Homing to the Blood-Brain BarrierPeter Conaty, Lauren S Sherman, Yahaira Naaldijk, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2009
RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cellsBobby Y Reddy, Steven J Greco, Prem S Patel, et al.
Cancer Letters|March 18, 2014
Is reduction of tumor burden sufficient for the 21st century?George Nahas, Sarah A Bliss, Garima Sinha, et al.
Pageof 20

Showing results (91-100 of 196) with videos related to

Sort By:
Pageof 20
Cancer Metastasis Reviews|May 13, 2020
Epigenetic dynamics in cancer stem cell dormancyAlejandra I Ferrer, Jonathan R Trinidad, Oleta Sandiford, et al.
Molecular and Cellular Therapies|June 10, 2015
Stem cell in alternative treatments for brain tumors: potential for gene deliveryVeronica Mariotti, Steven J Greco, Ryan D Mohan, et al.
Current Drug Discovery Technologies|June 10, 2008
Neurokinin receptors as potential targets in breast cancer treatmentBobby Y Reddy, Katarzyna A Trzaska, Raghav G Murthy, et al.
Experimental Hematology|September 13, 2002
Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptorPranela Rameshwar, Pedro Gascon, Hyun S Oh, et al.
Canadian Journal of Physiology and Pharmacology|June 12, 2002
Structural similarity between the bone marrow extracellular matrix protein and neurokinin 1 could be the limiting factor in the hematopoietic effects of substance PPranela Rameshwar, Pedro Gascon, Persis S Bandari, et al.
Shock (Augusta, Ga.)|October 19, 2004
A theoretical simulation of hematopoietic stem cells during oxygen fluctuations: prediction of bone marrow responses during hemorrhagic shockEliana S Antoniou, Steve Sund, Emile N Homsi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigensJulius A Potian, Hana Aviv, Nicholas M Ponzio, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 10, 2018
Methods of Mesenchymal Stem Cell Homing to the Blood-Brain BarrierPeter Conaty, Lauren S Sherman, Yahaira Naaldijk, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2009
RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cellsBobby Y Reddy, Steven J Greco, Prem S Patel, et al.
Cancer Letters|March 18, 2014
Is reduction of tumor burden sufficient for the 21st century?George Nahas, Sarah A Bliss, Garima Sinha, et al.
Pageof 20